Peak expiratory flow

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Peak expiratory flow
Peak flow meter horiz.jpg
A peak flow meter issued in the UK.
MeSH D010366

The peak expiratory flow (PEF), also called peak expiratory flow rate (PEFR) is a person's maximum speed of expiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe out air. It measures the airflow through the bronchi and thus the degree of obstruction in the airways.


Peak flow readings are higher when patients are well, and lower when the airways are constricted. From changes in recorded values, patients and doctors may determine lung functionality, severity of asthma symptoms, and treatment.

First measure of precaution would be to check patient for signs and symptoms of asthmatic hypervolemia. This would indicate whether or not to even continue with the Peak Flow Meter procedure. Measurement of PEFR requires training to correctly use a meter and the normal expected value depends on a patient's sex, age and height. It is classically reduced in obstructive lung disorders such as asthma.

Due to the wide range of ‘normal' values and high degree of variability, peak flow is not the recommended test to identify asthma. However, it can be useful in some circumstances.

A small portion of people with asthma may benefit from regular peak flow monitoring. When monitoring is recommended, it is usually done in addition to reviewing asthma symptoms and frequency of reliever medication use.[1]

When peak flow is being monitored regularly, the results may be recorded on a peak flow chart.

It is important to use the same peak flow meter every time.


Normal values, shown on EU scale.[2]
This peak flow meter uses the EU scale.

There are a number of non-equivalent scales used in the measurement of Peak Flow.[3]

Graphs or tables are available of predicted normal values based on a person's sex, age and height, and online calculators are available. There is a wide natural variation in results from healthy test subjects.

In 2004 the UK switched from the original Wright scale to the newer, more accurate European scale. Wright values may be converted to the EU scale using the following formula:[7]

 \text{EU} {{=}} 50.356 + (0.4 \times \text{Wright}) + (0.0008814 \times \text{Wright}^2) - (0.0000001116 \times \text{Wright}^3)

The reverse calculation is:

 \text{Wright} {{=}} -61.1 + (1.798 \times \text{EU}) - (0.001594 \times \text{EU}^2) + (0.0000007713 \times \text{EU}^3)


The highest of three readings is used as the recorded value of the Peak Expiratory Flow Rate. It may be plotted out on graph paper charts together with a record of symptoms or using peak flow charting software. This allows patients to self-monitor and pass information back to their doctor or nurse.[8]

Peak flow readings are often classified into 3 zones of measurement according to the American Lung Association;[9] green, yellow, and red. Doctors and health practitioners can develop an asthma management plan based on the green-yellow-red zones.

Zone Reading Description
Green Zone 80 to 100 percent of the usual or normal peak flow readings are clear. A peak flow reading in the green zone indicates that the asthma is under good control.
Yellow Zone 50 to 79 percent of the usual or normal peak flow readings Indicates caution. It may mean respiratory airways are narrowing and additional medication may be required.
Red Zone Less than 50 percent of the usual or normal peak flow readings Indicates a medical emergency. Severe airway narrowing may be occurring and immediate action needs to be taken. This would usually involve contacting a doctor or hospital.


The measurement of peak expiratory flow was pioneered by Martin Wright, who produced the first meter specifically designed to measure this index of lung function. Since the original design of instrument was introduced in the late 1950s, and the subsequent development of a more portable, lower cost version (the "Mini-Wright" peak flow meter), other designs and copies have become available across the world.[10]

See also[edit]


  1. ^ National Asthma Council of Australia
  2. ^ Nunn, A. J., and I. Gregg. 1989. New regression equations for predicting peak expiratory flow in adults. Br. Med. J. 298: 1068-1070. Adapted by Clement Clarke for use in EU scale - see > Predictive Normal Values (Nomogram, EU scale)
  3. ^ Martin R. Miller (June 2004). "Peak expiratory flow meter scale changes: implications for patients and health professionals" (PDF). The Airways Journal 2 (2): 80. Retrieved 2006-06-06. 
  4. ^ Nunn A, Gregg I (1989). "New regression equations for predicting peak expiratory flow in adults". BMJ 298 (6680): 1068–70. doi:10.1136/bmj.298.6680.1068. PMC 1836460. PMID 2497892.  - Predicted peak expiratory flow in normal adults using Wright-scale
  5. ^ Godfrey S, Kamburoff PL, Naim JL (1970). "Spirometry, lung volumes and airway resistance in normal children ages 5 to 18". Br J Dis Chest 64 (1): 15–24. doi:10.1016/S0007-0971(70)80045-6. PMID 5438753.  - Predicted peak expiratory flow in normal children using Wright-scale
  6. ^ Clement Clarke International (2004). "Predictive Normal Values (Nomogram, EU scale)". Clement Clarke International. Retrieved 2006-06-06.  - Downloadable PDF charts for adults and children using EU scale
  7. ^ Clement Clarke International (2004). "Mini-Wright Peak Flow Meter - Wright to EU (EN13826) converter" (EXE MACROMEDIA FLASH). Clement Clarke International. Retrieved 2006-06-06. [dead link]
  8. ^ Scottish Intercollegiate Guidelines Network & The British Thoracic Society (July 2007). "British Guideline on the Management of Asthma - Annex 8: Personal Asthma Action Plan" (PDF). Thorax 58: Suppl I. Retrieved 2011-10-27.  - for recording chart of PEFR readings
  9. ^ American Lung Association. "How can I determine a normal peak flow rate for me?". 
  10. ^ WRIGHT BM, McKERROW CB (November 1959). "Maximum forced expiratory flow rate as a measure of ventilatory capacity: with a description of a new portable instrument for measuring it". Br Med J 2 (5159): 1041–6. doi:10.1136/bmj.2.5159.1041. PMC 1990874. PMID 13846051. Retrieved 2014-06-02.